You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 244 Novel respirable antisense oligonucleotide (RASON) approach to primary and metastatic human lung cancer: preliminary results in a model system employing spontaneous lung tumors in dogs

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
244 Novel respirable antisense oligonucleotide (RASON) approach to primary and metastatic human lung cancer: preliminary results in a model system employing spontaneous lung tumors in dogs

 

Online download statistics by month:

Online download statistics by month: November 2020 to July 2025

AbstractFullPdf
Nov 202094013
Dec 2020105017
Jan 20212004
Feb 20211004
Mar 20211207
Apr 20212602
May 2021407
Jun 2021006
Jul 2021007
Aug 2021005
Sep 2021008
Oct 20218026
Nov 202118013
Dec 2021806
Jan 20221000
Feb 2022807
Mar 2022401
Apr 20221001
May 20221207
Jun 20221608
Jul 20221206
Aug 2022600
Sep 20221609
Oct 20224205
Nov 20221803
Dec 20222204
Jan 2023404
Feb 2023800
Mar 2023201
Apr 20231602
May 20231100
Jun 2023202
Jul 2023204
Aug 20231202
Sep 20231401
Oct 2023204
Nov 20231403
Dec 20232201
Jan 2024800
Feb 2024603
Mar 202424029
Apr 2024406
May 20241402
Jun 20241201
Jul 2024201
Aug 2024407
Sep 2024804
Oct 2024602
Nov 2024801
Dec 20241603
Jan 2025607
Feb 2025606
Mar 2025005
Apr 2025005
Jun 2025004
Jul 2025002
Total7140288